secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0001193125-24-009264
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo reports prelim Q4 revenue $4.6-$4.8M (+14-19% YoY), raises $6M in registered direct offering
--------------------------------------------------------------------------------

- Preliminary Q4 2023 revenue expected $4.6-$4.8M, up 14-19% YoY; cash $8.7M at Dec 31, 2023.
- Backlog of ~230 patients as of Dec 31, 2023, up ~40% YoY; CMS classified MyoPro as a brace, reimbursed lump sum.
- Raised $6M gross via registered direct offering of 1.58M shares/pre-funded warrants at $3.80, priced at market.
- Proceeds to scale up for Medicare Part B, hire ~50 people; expects cash flow breakeven by Q4 2024.
- CEO targets $100M annual revenue within five years; offering includes insiders and institutional investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000119312524009264/0001193125-24-009264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000119312524009264/d573347d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-009264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer